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We have tested the effectiveness of polyethylene glycol (PEG) to restore the integrity of 
neuronal membranes after mechanical damage secondary to severe traumatic brain injury (TBI) 
produced by a standardized head injury model in rats. We provide additional detail on the 
standardization of this model, particularly the use and storage of foam bedding that serves to 
both support the animal during the impact procedure and to dampen the acceleration of the brass 
weight. Further, we employed a dye exclusion technique using ethidium bromide (EB; 
quantitative evaluation) and horseradish peroxidase (HRP; qualitative evaluation). Both have 
been successfully used previously to evaluate neural injury in the spinal cord since they enter 
cells when their plasma membranes are damaged. We quantified EB labeling (90 M in 110 L 
of sterile saline) after injection into the left lateral ventricle of the rat brain 2 h after injury. At six 
h after injection and 8 h after injury, the animals were sacrificed and the brains were analyzed. In 
the injured rat brain, EB entered cells lining and medial to the ventricles, particularly the axons 
of the corpus callosum. There was minimal EB labeling in uninjured control brains, limited to 
cells lining the luminal surfaces of the ventricles. Intravenous injections of PEG (1 cc of saline, 
30% by volume, 2000 MW) immediately after severe TBI resulted in significantly decreased EB 
uptake compared with injured control animals. A similar result was achieved using the larger 
marker, HRP. PEG-treated brains closely resembled those of uninjured animals. 
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In the United States, the leading cause of death and disability for children and adults is traumatic 
brain injury (TBI). One and a half million Americans are injured each year; 230,000 of these 
people are hospitalized, but survive their injury, while 50,000 die. Approximately 80,000–90,000 
sustain disabilities that affect them over a long period of time, indeed often the rest of their lives 
(Thurman et al., 1999). Currently, pharmacological treatments are not available to these patients 
that have been shown to produce substantial benefits (Vink et al., 2001). Mechanical damage to 
cell membranes associated with TBI is believed to progress from an initial ionic derangement 
when the permeability barrier provided by the plasmalemma is breached (Borgens, 1988; 
Povlishock et al., 1997). This may eventually produce necrotic or apoptotic cell death (Shapira et 
al., 1989; Gwag et al., 1999; Zipfel et al., 2000). This progressive loss of parenchyma is often 
referred to as “secondary injury” and may occur for many hours to days post-injury (Borgens, 
2003). The most immediate—and clinically relevant—consequence, however, is the loss in 
neuronal excitability producing initial and progressive functional losses (Borgens, 2003). Many 
different pharmacological approaches that mitigate the pathological responses to TBI have been 
developed and tested (Keane, 2001; Vink et al., 2001). In experimental animals, promising 
avenues include the use of serine protease inhibitors (Movsesyan et al., 2001), caspase and 
calpain inhibitors (Buki et al., 2004; Feng et al., 2003), and mild, post-traumatic hypothermia 
(Koizumi and Povlishock, 1998). However, the injury pathway associated with mechanical 
trauma to cells involves many factors (Roy and Sapolsky, 1999; Raghupathi et al., 2000; 
Borgens, 2003), and there are still significant theoretical and practical hurdles in applying this 
knowledge to the development of clinical therapies for severe head injury. 
 
Several families of inorganic hydrophilic polymers [poloxamers, poloxamines, polyethylene 
glycol (PEG)] are able to immediately reconstitute cell membrane damaged by mechanical injury 
(Borgens, 2003). PEG is a non-toxic substance that can be injected into the bloodstream and has 
been shown to both fuse and/or repair damaged cell membranes to stave the potential for ion 
influx and the resulting cell death cascade (Borgens, 2001). Topical application to isolated and 
injured guinea pig spinal cord white matter in vitro—or topical or intravenous application of 
PEG in vivo—can reverse physiological conduction block, and dramatically increase the number 
of surviving axons and thus the overall amount of spared white matter. This is associated with a 
rapid physiological and/or functional recovery in mammals (Borgens 2001, 2003). PEG has also 
been shown to inhibit free radical production (Luo et al., 2002) and reduce oxidative stress 
resulting from spinal cord injury (Luo et al., 2004). 
 
Here, for the first time, we test the effectiveness of intravenous PEG administration in adult rats 
as a prophylactic to advancing cell disruption and death after traumatic TBI. To evaluate PEG’s 
effect on cell damage, ethidium bromide (EB) was injected into the ventricular space two hours 
after injury and allowed to diffuse into brain tissue for six hours. EB has been used previously to 
detect neural injury in the spinal cord (Luo et al., 2002) because it selectively labels cells when 
their plasma membrane is compromised (Aeschbacher et al., 1986; Luo et al., 2002). When this 
fluorochrome moves unobstructed into the cytoplasmic compartment, its fluorescent intensity 
increases 40-fold after binding to nucleic acids, which also inhibits back-diffusion (Aeschbacher 
et al., 1986; Dey and Majumder, 1988; Sun-Kyung and Hollenbeck, 1995; Koenig and Giuditta, 
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1999; Luo et al, 2002; Piper and Holt, 2004). Our results indicate intravenous treatment with 
PEG substantially prevents the uptake of this label into cerebral cells after TBI, further 




MATERIALS AND METHODS 
 
Impact Acceleration Injury Model 
 
The impact acceleration brain injury device (Marmarou et al., 1994) (Fig. 1) produces injury to 
cells within the brain. Typical regions of the brain are particularly vulnerable after impact, 
including cells and processes within the corpus callosum, corona radiata, and brain stem, as well 
as subarachnoid hemorrhage in severe cases within the forebrain and hindbrain (Foda and 
Marmarou, 1994). Further descriptive and methodological details of this model can be found 
elsewhere (Nawashiro, 1995; Nawashiro et al., 1995; Povlishock et al., 1997). 
 
A total of 20 rats was used in this study. For the quantitative evaluation of EB labeling, three 
groups of four animals weighing 400–450 g were initially anesthetized with 4% isoflurane in 
99% oxygen. They were endotracheally intubated and ventilated with 1.5–2.5% isoflurane in 
99% oxygen on a Harvard Apparatus Small Animal Volume Controlled Ventilator (model 683). 
Body temperature was maintained with a Harvard Apparatus Homeothermic Blanket Control 
Unit (catalog no. BS4 50- 7053-R). A superficial midline incision to the scalp was performed, 
after which the periosteal membranes were removed to expose the skull. A metal disk (referred 
to below as a “helmet”), 10 mm in diameter and 3 mm wide, was firmly attached to the exposed 
bone with dental acrylic and Loctite QuickTite super glue gel between lambda and bregma 
sutures (Fig. 1). With one exception, a 450-g brass weight was dropped from a height of 2 m 
through a Plexiglas delivery tube onto the disc to produce a severe injury. The exception was 
qualitative data derived from Hemotoxylin and Eosin staining, which was performed early in 
these investigations after a 1.5-m drop. Immediately after the injury, a 1-cc intravenous injection 
of sterile saline or PEG-saline solution (2000 MW, 30% by volume) was administered into the 






FIG. 1. Impact acceleration model. (A) Dorsal (top) and lateral (bottom) view of rat skull. The 
position of the metal helmet (green) is shown placed between the bregma suture (rostral) and the 
lambda suture (caudal). (B) From left to right: The photograph shows the impact acceleration 
device, whereas the adjacent diagram provides further detail; a brass weight (18 mm diameter, 7 
in long, 450 g) was dropped from varying heights to provide different degrees of injury. The rat 
was positioned on a foam bed as shown; the insets provide detail of the helmet. A ventral view 
(top) of the helmet shows the concentric grooves, which provide purchase against the skull, and 




Uninjured control animals received identical surgical and anesthetic methods, but without TBI (a 
weight was dropped near but not on the animal, referred to below as “sham” injury or “controls”) 
or an injection of saline or PEG. After injury, animals were also injected intramuscularly with 
0.075 mg/kg of buprenorphine HCl, allowed 15–20 min on 1.5% isoflurane in 99% oxygen. 
Afterwards, they were ventilated for 10 min on 99% oxygen alone and 10 min on room air. Then 
the animals were checked periodically and taken off the ventilator when they were able to 
breathe on their own. All of these procedures were both formally reviewed and approved by the 
Purdue University Animal Care and Use committee.  
 




Calculating the weight rebound in relation to the Head Injury Criteria (HIC), we found foam 
when new was within 10–15% of Marmarou’s measurements (HIC [in g] = a−2.5*t). Note that 
the average acceleration of the brass weight while in contact with the foam was also greater for 
newly purchased foam compared with aged foam. The aged foam dampened the weight, 
resulting in a longer time of contact, slowing the impact, and lessening the severity of the injury. 
 
Injury Standardization: Foam Rebound 
 
Measurements of displacement and rebound of the brass weight (18 mm diameter, 7 in long, 450 
g) directly onto the foam substrate (12 cm high, 43 cm long, 13 cm wide) that supports the rat 
during injury were made using a standard metric ruler by straightforward means. The foam tested 
was newly purchased foam (Foam to Size, Ashland, VA, type E bed) and old foam (exposed to 
light and 6 months old after purchase—same vendor). The weight was dropped from 2 m and the 
maximum impact into the foam was measured as well as the maximum height of the rebound of 
the weight. The spring constant and damping constant of the foam were determined from these 
measurements. The two types of foam were compared to data provided for foam bedding in 
Marmarou et al., 1994 using the equation of motion based upon Newton’s second law,  
A(d2x/dt2) + B(dx/dt) + Cx = D, where A = mass = 0.45 kg; B =  = 20.4 N-sec/m; C = k (spring 
constant of the foam) = 2500 Nt/m; and D = constant = mass * gravity = 4.41 Newtons. The 
acceleration and time of weight impact in the foam was calculated in relation to the Head Injury 
Criteria (HIC = a−2.5 * t, where a is the mean acceleration during impact and t is the duration 
of the impact) (Versace, 1971; Margulies and Thibault, 1992) for further comparison (Table 1). 
For these calculations the acceleration and contact time for the 450-g weight alone were assumed 




Dye Exclusion Test 
 
Two hours post injury or sham injury in each animal a small hole was drilled into the skull (1.4 
mm left of midline; 0.5 mm caudal to bregma) (Singleton and Povlishock, 2004), and an 
injection of EB (400 MW, 90 M EB in 110 L of saline) was performed with a 23-gauge 
needle 4 mm deep into the brain into the left lateral ventricle (Fig. 2). This procedure was 
facilitated using a KOPF model 900 small animal stereotaxic device. The EB was slowly injected 
into the ventricle for approximately 30 min. Subsequently, the needle was allowed to remain in 
place for another 10 min before removal. This procedure eliminated the propensity for accidental 
aspiration of the remaining and local substance when the needle was withdrawn. At 6 h after the 
intraventricular injection of EB and 8 h after injury, rats were anesthetized with 1 cc sodium 
pentobarbital (160 mg/kg) underwent intracardiac perfusion with lactated Ringer’s solution (60% 
NaCl, 31% C3H5NaO3 [anhydrous], 0.3% KCl, 0.2% CaCl2 [dihydrate] by volume in distilled 
H2O) followed by 4% paraformaldehyde, 1% glutaraldehyde in phosphate buffered saline 
solution (PBS; normal saline buffered with 0.02 M NaH2PO4; 0.1 M Na 2HPO4; pH 7.4). The 
brains were then removed and placed in PBS overnight. The cerebellum and brain stem were 
discarded after dissection and coronal frozen sections at 40 m were taken posterior (caudal) to 
EB injection site. Histological sections were adhered to slides, dehydrated through water, 70% 
alcohol, 90% alcohol, and 100% alcohol (2 min each). They were then placed in xylene for 1 h 







FIG. 2. Experimental procedure. (A) Drawing of the rat brain in coronal section. The inset 
shows the approximate plane of section, 0.5 mm caudal to bregma. Note the position of a 23-
gauge hypodermic needle used to deliver intracellular markers into the left lateral ventricle. The 
anesthetized animal’s head is held in place in a stereotaxic frame to facilitate the injection. 
Below the drawings, the experimental timeline of 8 h is depicted. The injection of PEG or 
control solution is made within 15 min after injury (followed by a marker dye injection 
approximately 2 h post-injury). This latter procedure takes 30 min. A delay of 10 min was used 
prior to removal of the needle. (This delay permits sufficient diffusion of the marker from its 
source. If the delay is not used, then some of the marker may be aspirated into the needle tract 
when it is withdrawn.) 
 
 
Sections were observed with an Olympus BX-61 fluorescent microscope (excitation filter, BP 
545 nm; barrier filter, 0–590 nm; Olympus America Inc., Melville, NY), and EB fluorescent 
images of complete coronal sections were photographed using a 4x objective and a high 
resolution CCD camera (Olympus CC12). Since the histological sections were large, the sample 
could not be completely captured within a single field of view. Twenty images at this 
magnification were required to produce a montage using MicroSuite software (Soft Imaging 
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System, Lakewood, CO) automated with a Ludl® motorized stage. The completed montage 
provided a complete view of the histological section.  
 
Exposure settings were held constant during the capture of all digital images. Using a full 
coronal montage, an area between the lateral and third ventricles in a region within 1–2 mm 
posterior to the site of EB injection was circumscribed. Montages were obtained from this area 
from each animal. The acquisition and analysis of the fluorescent intensity data inside the sample 
area was completed using an image analysis program, Sigmascan Pro (SPSS Science, Chicago, 
IL) and adjusted for background fluorescence. The mean fluorescent intensity of the three 
sections for each animal was calculated. Units of luminosity (LUM) was determined from pixel 
values, and in the software used, ranged from 0 (black) to 256 (white) (Luo et al., 2003; Teng et 
al., 2004). All photomicrographs were taken at the same exposure, and in each montage, the 
mean luminosity of the lateral cortex contralateral to the injection site was subtracted from the 
mean luminosity of the region of interest to eliminate background fluorescence between sections 
(i.b.i.d.). These procedures were carried out on coded samples by personnel unaware of the 
experimental status of the animals provided them. The means for four animals in each group 
were averaged and statistically analyzed between groups with one-way ANOVA and Student-
Newman-Keuls multiple comparisons tests. Significance was established with p values of < 0.05.  
 
Three-Dimensional Visualization  
 
Acquisition of serial images. Transverse fluorescent sections were consecutively viewed at low 
magnification (2x) on an Olympus® BX61 automated light microscope and captured by an 
Olympus® CC12 digital video camera mounted on top. (Transverse sections were only used in 
this imaging as the whole brain could be sectioned with fewer number of histological sections.) 
The brain sections were too large to be captured within a single field of view. Therefore, each 
image was assembled from a montage of up to twelve smaller captured regions of interest using 
Microsuite-B3SV software (Soft Imaging System, Lakewood, CO) controlling a Ludl® 
motorized stage. The exposure rate was fixed to maintain uniform excitation of the fluorescent-
labeled sections with a rhodamine filter cube.  
 
Registration of the dataset. Automatic registration was achieved by choosing control (fiducial) 
points between adjacent pairs and carrying out a transformation on one image so that it closely 
matched the other. This was conducted based on correlating two adjacent images at a time—
specifically, the TARGET image was registered to the BASE image. For example, when image i 
was registered to i-1, the transformation applied to image i involved the overall transformation 
that has been applied to image i-1 plus the new transformation between images i and i-1, and so 
on. In this way, all subsequent images in the data set were finally registered to the first image. 
Images were also converted from RGB (red, green, and blue components) to the format of HSV 
(hue, saturation, and value), and only the value component (intensity) was be used in the later 
steps. Since our goal was to obtain the corresponding points in the BASE and TARGET images, 
the most representative corresponding points would be those that critically defined the shape of 




Three-dimensional reconstruction. To ensure accuracy of the three-dimensional (3D) 
reconstructions, every histological section comprising one data set for each brain was used, 
except the rare occasion where a histological section was lost or unusable. In the figure shown, 
visualizations of injured and uninjured brains were constructed from 246 and 237 serial sections, 
respectively (Fig. 3). The final 3D reconstruction was accomplished using an isocontouring 
software application developed by Bajaj et al. (1997) running on a Silicon Graphics® Indigo 
workstation (Mountain View, CA). This procedure allowed only biological features that were 
consistent in two or more sections to be 3D reconstructed, thus eliminating any outlier 
histological defects from the 3D image (Duerstock et al., 2000). The quantification of imbedded 
structures within the 3D image used a spectral interface to select the isocontours of the whole 
brain and EB-labeled regions. The wireframe surfaces were automatically divided into 
tetrahedral subcomponents that were computed using a B-spline function to calculate volume and 
surface area. These procedures have been standardized, validated, reported, and used in prior 
investigations (Bajaj et al., 1997; Duerstock et al., 2000, 2003).  
 
Given greater experience using horseradish peroxidase (HRP) as an intracellular label in injured 
nervous tissue (Borgens et al., 1986), we initially confirmed the dye-exclusion test in brain using 
this label. HRP (40,000 Daltons 30% by volume in 150 L of saline) was injected two hours 
after injury or sham injury. These animals were a separate group from those tested with EB, and 
were sacrificed 8 hours after injection by perfusion with lactated ringers followed by 6% 
paraformaldehyde 0.5% glutaraldehyde in PBS. Frozen sections were taken as described above. 
The HRP stained sections were placed in PBS for 10 min. Afterwards, they were immersed in 
cacodylate buffer (pH 5.1) for 15 min. They were then placed in 0.03% 3,3-diaminobenzadine 
(DAB) in cacodylate buffer (pH 5.1) for 30 min. Hydrogen peroxide was added to this solution at 
0.08% and the sections were allowed to sit another 10 min. Afterwards, they were rinsed in PBS, 
dehydrated through levels of alcohols as described above, placed in xylene, cover-slipped with 
Permount, and analyzed with the light microscope.  
 
Confirmation of PEG Distribution in Injured Brain 
 
To determine whether PEG could enter regions of interest in damaged brain after intravenous 
injection, we injected fluorescently-labeled PEG (fluorescein-5- thioureidyl-poly [ethylene 
glycol] methyl ether [FITCPEG, Molecular Probes, Eugene, OR], 2500 MW, 1 cc, 30% by 
volume in saline) into the rat tail vein immediately after injury. Animals were sacrificed 24 h 
after injury, and the brains were sectioned and prepared as described above. Observations of 
these sections were made with an Olympus Van Ox Universal fluorescent microscope (excitation 








FIG. 3. Ethidium bromide (EB) presence in injured and uninjured brains by three-dimensional 
reconstructions. A and B show different views of an EB-labeled uninjured rat brain three-
dimensionally reconstructed from serial transverse. The brain (rendered in red) was made 
transparent to reveal the internal region of fluorescence shown in light gray. (A) The dorsal 
surface of the brain (red) is shown with the rostral end toward the bottom of the page. (B) Side 
view of this brain and EB-specific labeling. The frontal lobe is on the right side, dorsal to the top 
of the page. C and D are separate views of a three-dimensional reconstruction of an injured brain 
labeled with EB. (C, D) Images are presented in an identical orientation as A and B, respectively. 







Standardization of the Injury Model The use of this injury model has been reported in various 
publications (Heath and Vink, 1996; Povlishock et al., 1997; Cernak et al., 2002); however, one 
parameter was found to be crucial to the standardization of the injury between animals that 
required further investigation and evaluation. Curiously, this factor was the character of the foam 
bedding supporting the animal during impact. Calculations of the expected weight rebound were 
made using data from Marmarou et al., 1994 and compared to physical measurements of the 
weight rebound onto newly purchased and stored foam (with appreciation of the standard HIC) 
(Versace, 1971; Margulies and Thibault, 1992). The spring and damping constants (k and ) 
measured from bedding foam when new were similar to the parameters reported by Marmarou et 
al. (1994) (Fig. 4, Table 1). The spring and damping constants for foam aged more than six 
months and exposed to light were different (k = 2400 and 1200 Nt/m, respectfully;  = 29 and 25 
N-sec/m, respectively). Based on these measurements, we determined that foam must be placed 











FIG. 4. Standardization of injury: contribution of the foam bedding. Physical characteristics of 
the foam bedding: the spring constant and damping constant effect outcome measures after 
impact. (A) Calculated characteristics of data from Marmarou et al. (1994) (k = 2500 Nt/m;  = 
20.4 N-sec/m). (B) Newly purchased foam (k = 2400 Nt/m;  = 29 Nsec/ m). (C) Foam aged 
more than 2 months and exposed to light (k = 1200 Nt/m;  = 25 N-sec/m). Top graph = 
displacement of the foam in meters. Middle graph = velocity of the weight while in contact with 
the foam. Bottom graph = acceleration of the weight when in contact with the foam. Note the 
marked difference between old foam relative to new foam and the latter’s similarities to that 






FIG. 5. Qualitative features of impact injury. (A) An area of the superficial sensory cortex is 
shown in an uninjured brain. Note the clear open nuclei with chromatin granules characteristic of 
uninjured rat brain cortex. (B) A similar location in the cortex 24 h after a 1.5-m impact is 
shown. Note the presence of condensed pyknotic cells. (C) Severe injury to the cortex was 
produced by a 2-m impact. Any evidence for spared neurons in these sections was scant. All 
brains were stained with Hemotoxylin and Eosin at 24 h after injury or sham treatment. Bar = 




Qualitative analysis to confirm a standardized injury to the brain was obtained from the cortex 
below the impact site using histological sections stained with a standard Harris’ Hemotoxylin 
and conventional histological procedures (Fig. 5). Cortical neurons in rats receiving a severe 
injury (2-m drop) or moderate injury (1.5 m) illustrated pyknotic characteristics compared to 
neurons in uninjured control animals and in uninjured regions of the test brains. All further 
experiments were carried out using the more severe injury (2-m drop). PEG Enters Damaged 
Regions of the Brain Fluorescently labeled PEG crossed the damaged blood–brain barrier after 
TBI (Fig. 6). We found that fluorescent PEG had entered areas of the injured cortex (Fig. 6A) 
but only modestly above the level of detection. There was less fluorescence in uninjured brains 
in animals injected with fluorescent PEG (Fig. 6B) as compared to uninjured animals that had 
not been not injected with fluorescent PEG (Fig. 6A). Regions of the brain stem in injured brains 
receiving fluorescent PEG injection were markedly labeled (Fig. 6B). The corpus callosum 
apical to the hippocampus and adjacent to the ventricles was labeled with fluorescent PEG, 
indicating that the polymer penetrated and diffused throughout this area (Fig. 6C). The 
accompanying pseudocolor graphic reveals the intense PEG fluorescence associated with the 
lateral edges of the caudal pontine region after injury, grading to low levels medial to this region 
(Fig. 6D). In summary, PEG labeling was consistently found in characteristic areas of brain 
injury experienced in the impact acceleration injury model. 
 
Confirmation of Dye Exclusion Procedures 
 
The procedure of dye exclusion as an index of cellular injury in the central nervous system has 
been previously established with horseradish peroxidase (HRP) in the spinal cord (Shi and Pryor, 
2000) and brain (Singleton and Povlishock, 2004). We qualitatively tested the uptake of this 
more conventional marker secondary to intraventricular injection prior to the routine use of EB. 
HRP was able to diffuse into the brain to areas such as the cortex dorsal and medial to the 
cingulum bundle, where damaged cells and portions of cells were clearly marked (Fig. 7A). Cells 
in an identical region of the control brain showed little to no uptake of HRP compared with the 







FIG. 6. Polyethylene glycol (PEG) distribution in injured and uninjured brain. Intravenous PEG 
preferentially labels regions of damage in brain. (A, B) In B, intravenously administered 
fluorescent PEG is barely detectable compared to background fluorescence in regions of 
uninjured cortex near the sagittal fissure; this brain looked similar to the low level of endogenous 
fluorescence apparent in A, an uninjured brain that did not receive intravenous PEG. (A,B) In 
A, PEG diffusely labeled identical regions of the brain after impact injury; B shows the diffuse 
fluorescence in the brain stem after injury in a rat receiving intravenous PEG injection. These 
photomicrographs are unaltered video captures. (C, D) In C, PEG labeling in a region of the 
injured corpus callosum (arrow points to the lateral ventricles); D is a pseudocolor image 
revealing a gradient of PEG labeling from relatively high concentration (light blue), diminishing 
to dark blue, and black in the lateral edges of the caudal pontine region.  (Inset) Unaltered video 







FIG. 7. Dye exclusion procedure. (A) Uptake of horseradish peroxidase (HRP; 150 L, 30% in 
saline) was injected as shown in Figure 2. Note that the arrows point to well-labeled injured cells 
that imbibed the marker dorsal and medial to the cingulum bundle. Labeling occurs in cell bodies 
as well as cell processes such as dendrite and axons. (B) Identical regions of an uninjured rat 
brain treated similarly to the animal shown in A. Note the complete absence of HRP uptake by 







After injection into the left lateral ventricle of the rat brain after injury, EB entered cells near the 
ventricles, including the axons of the corpus callosum directly apical to the lateral ventricles 
(Figs. 8B and 9A, B) while EB labeling in uninjured brains was minimal (Figs. 8A and 9C). EB 
labeling in PEG-treated injured brains was significantly less than that observed in injured brains 
(Figs. 8C and 9D). Moreover, the minimal level of EB fluorescence in PEG-treated brains was 
similar to uninjured brains (Table 2). 
 
The fluorescent intensity of EB was first calculated including the lateral and third ventricles (Fig. 
10). Injured untreated brains had significantly more fluorescence than both uninjured controls (p 
< 0.01) or injured PEG treated brains (p < 0.01). The fluorescent intensity in uninjured control 
and injured PEG-treated brains was also significantly different (p < 0.05) when the fluorescence 
associated with the ventricles was included. The lining of the ventricles that was labeled in all 
brains evaluated was excluded in a separate determination of fluorescence (Fig. 11 and Table 3). 
These measurements clarified EB uptake—limiting evaluation to deeper regions of the corpus 
callosum—and the result was essentially the same as described above, yet more marked: PEG-
treated and uninjured control animals were not significantly different from each other (p < 0.05). 
Fluorescent intensity in injured yet untreated brains was statistically significantly greater 
compared to uninjured controls and injured but PEG-treated brains (p < 0.01). Fluorescence 
associated with labeling of only the ventricular lining was normalized ([fluorescent intensity 
including ventricles] x [fluorescent intensity between ventricles]) which revealed that this 
labeling was statistically similar between all groups (Fig. 11). Labels that mark cellular 
inclusions such as EB do not yield the most complete or uniform morphology. Thus, labeling of 
axons of the corpus callosum was discontinuous. Small cells, likely glia, were also labeled in this 
region (Fig. 9B). HRP-injected brains provided more familiar morphology of neurons and axons 
in the region of damage—in particular, the subcortical regions at the unilateral site of impact. 
Here HRP uptake by cells was heavy in injured animals (but not in the contralateral hemisphere) 
and absent in uninjured controls (Fig 7). Confirming the data provided by EB, HRP labeling was 






FIG. 8. Ethidium bromide labeling in polyethylene glycol (PEG)–treated and untreated brains. 
(A) Coronal section of an uninjured rat brain is shown caudal to the injection site. Note the 
fluorescence at the lining of the left ventricle. There is less labeling in this region contralateral to 
the site of injection. (B) Similarly treated but injured rat brain. Note the intense labeling in 
regions adjacent to, but not limited to, the lining of the ventricle. (C) Similar photo montage 
shows the response to PEG injection in the injured rat brain. Note the more restricted labeling 
compared to B, and the qualitative similarity to the control brain in A. The green box in C marks 
the region in which quantitative measures of fluorescence were obtained to include the lateral 
and third ventricles. The blue box shows the region in which quantitative measures were 
obtained between the ventricles. Each image is a montage of 16–20 fields of view at original 






FIG. 9. Rescue of neurons after brain injury in response to intravenous injection of polyethylene 
glycol (PEG). (A) Region of severe injury of the corpus callosum (cc) after 2-m impact. The 
intracellular label, as in Figure 8, was ethidium bromide (90 mM in 110 L of saline). Bar = 0.5 
mm. (B) Higher magnification view of the same region. Bar = 30 m. This image reveals that 
intense fluorescence at low magnification (and in thicker optical section) was due to the 
aggregate of mainly damaged axons fluorescing after imbibing the marker. Labeling is 
discontinuous in axons, as ethidium bromide (EB) labels nucleic acids and does not spread 
uniformly throughout the axoplasm. Other damaged cells, likely oligodendrocytes and other glia 
(inset), were also observed in this region. (C) Identical region to A, yet in an uninjured rat brain. 
Note the presence of fluorescence associated with the epithelium of the lateral ventricle (lv). (D) 
Injured rat brain treated with PEG is shown for comparison. Again, labeling is restricted largely 






TABLE 2. QUANTIFICATION OF EB LABELING IN INJURED AND UNINJURED 




The brain reconstructions were quantitatively compared for volume and surface area of the 
whole brain and the EB-labeled region “embedded” within. The uninjured brain was slightly 
smaller than the injured subject; therefore, the volume of EB labeling is shown as a percentage of 
the total brain volume. Though the overall sizes of the brains were different, the sizes of the 
ventricles were similar. We observed from the reconstructions and the component serial sections 
that EB labeling consistently revealed the same structures, including the third ventricle and left 
lateral ventricle. Thus, increased EB labeling in the injured brain constituted greater labeling of 
parenchyma over that associated with the ventricular spaces. The greatest extent of non-ventricle 
EB uptake in injured brain occurred rostral and superior to the third ventricle between the 






The impact acceleration injury, a closed head injury model, was originally developed to 
investigate traumatic axonal injury in brain. After standardizing the model and calibrating the 
foam bedding, we were able to reproduce the characteristics of injury reported previously—
including injury to the area of the corpus callosum (Foda et al., 1994). The axons of the corpus 
callosum show marked uptake of EB in injured brains as EB preferentially diffuses to those cells 
medial to the ventricles. Less extensive EB migration throughout lesioned regions (compared to 
HRP) was possibly due to the lesser amount of label used—or because as a smaller molecule it is 
imbibed rapidly in injured regions near the injection and is unavailable to injured soft tissues at 







FIG. 10. Quantitative evaluation of fluorescence in experimental rat brains, including ventricles. 
The means for fluorescent intensity of coronal sections including lateral and third ventricles 
(green box, Figure 8C). The fluorescent intensities from uninjured controls, injured untreated, 
and polyethylene glycol (PEG)–treated injured animals (n = 4 for each group) were calculated. 
Note the significant reduction in ethidium bromide fluorescence in injured brains produced by 
PEG injection (*p < 0.01). The fluorescence associated with ethidium bromide (EB) labeling in 
PEG-treated brains was significantly reduced compared to injured but untreated brains, yet still 
elevated relative to uninjured controls (**p < 0.05). 
 
 
While the ventricular lining may be damaged (and thus labeled) in impacted animals, we do not 
entirely understand why EB labels uninjured cells of the ventricular lining in uninjured animals. 
It is not likely that it is aggregating on the “sticky” surfaces of intact cells since complexing with 
nucleic acids is critical to its fluorescence. It is more likely that the label may be incorporated 
somehow during the natural turnover of these lining cells and that ependyma may perform some 
phagocytic functions in brain, thus actively endocytose the marker. When the fluorescence 
associated with ventricular lining was excluded from consideration however, an even greater 
difference was observed between injured untreated brains and injured PEG—treated brains. PEG 
application restricted transmembrane movement of extracellular EB to the inside of damaged 
cells. Such intracellular labeling was usually intense after TBI. Though our presentation of data 
has emphasized the tissue level, we emphasize that EB produces negligible fluorescence unless it 
enters the intracellular compartment and binds with nucleic acids. Non-neuronal cells, neurons, 
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and axons are replete with such reactive nucleic acids (Sun- Kyung and Hollenbeck, 1995; 
Koenig and Giuditta, 1999; Piper and Holt, 2004). The intense fluorescence after TBI in (a) 
regions of the brain vulnerable to impact in this model (such as the CC and superficial cortex), 
and (b) uninjured controls supports the hypothesis that EB labeling was indicative of significant 
cell membrane disruption after TBI. This reduction in EB uptake in PEG-treated brains was not 
associated with some mechanism unrelated to either injury or membrane sealing by PEG since 
PEG-treated and uninjured control brains were similar. Furthermore, the EB results were 
consistent with (1) our confirmation of the dye exclusion test using HRP relative to similar 
observations by others (Singleton and Povlishock, 2004), and the near elimination of this uptake 
after PEG treatment and (2) the results of similar dye exclusion tests performed using both in 
vitro and in vivo spinal cord with both labels (Luo et al., 2002; Shi and Pryor, 1999). It could 
also be that the time course of EB uptake may be affected by PEG; however, this seems less 






FIG. 11. Quantitative evaluation of fluorescence in experimental rat brains between ventricles. 
(A) Mean fluorescent intensity of coronal sections is shown excluding the superficial labeling of 
the lateral and third ventricles (blue box, Figure 8C). Ethidium bromide (EB) fluorescence in 
injured brains produced by polyethylene glycol (PEG) injection differed from injured control 
brains more dramatically when ventricular fluorescence was not considered (*p < 0.01). 
Statistical significance was similar to that shown in the comparison of uninjured controls and 
injured untreated animals in Figure 10 (*p < 0.01). When the fluorescence associated with the 
lining cells of the ventricles was not included in evaluations, there was no statistical difference 
between uninjured controls and injured PEG-treated animals (**p < 0.05). (B) Means of the 
difference in fluorescent intensity of coronal sections including (Fig. 10) and excluding (Fig. 
11A) ventricles was normalized ([fluorescent intensity including ventricles] x [fluorescent 
intensity between ventricles]) and compared. There was no significant difference between the 
groups, indicating that the fluorescence associated with lining cells of the ventricles was 
statistically similar for all groups. 
 
 





a Total fluorescence in units of luminosity (LUM) for all histological sections for all animals in 
this group. For determination of LUM, see text.  b A negative value can occur when the 







FIG. 12. Horseradish peroxidase (HRP) labeling of subcortical neurons in injured and 
polyethylene glycol (PEG)–treated brains. (A) A low magnification view of the subcortical 
region of a rat brain beneath the site of impact is shown. Note that damaged neurons are clearly 
labeled with HRP, including their long axons (arrows). (B) A higher magnification view of these 
cells. (C) Montage shows this identical region, but in an injured and PEG-treated animal. Note 
the complete lack of HRP-labeled CNS cells. Bar = 250 m (A), 50 m (B), 100 m (C). 
 
 
Molecular Markers as Indices of Membrane Disruption and Sealing 
 
In the reports cited here, we have suggested that it is likely a wide range of membrane defects 
may be repaired/ restored by inorganic polymer administration—and in all damaged cells, 
including non-neuronal support cells of the CNS (Borgens 2001 and 2003). Electrical excitability 
is immediately restored in crushed spinal cord in organ culture following PEG application—
though the magnitude of recovered compound action potentials (CAP) are clearly enhanced after 
a subsequent administration of a fast potassium channel blocker (4-aminopyridine) to the bathing 
medium (Shi and Borgens, 1999). The most parsimonious interpretation of this result is that the 
very rapid sealing ability of PEG (seconds to minutes) sufficient to restore CAP initiation and 
conduction, likely reduced the extent of ionic derangement after mechanical injury (restoring to 
some degree the permeability barrier to even ions). This seal is incomplete at the level of ion 
channels however, or potassium blockade would have no effect on the shape or magnitude of 
restored CAPS in the presence of PEG. In the injured spinal cord, we have used the loss of 
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Lactate Dehydrogenase (LDH) from the intracellular compartment into the extracellular milieu 
after injury as an index of cell compromise. PEG application significantly reduced the 
transmembrane movement of this label (Luo et al., 2002). Thus, PEG is able to seal membrane 
breaches in mammalian CNS cells sufficient to inhibit (a) the loss of very large markers from the 
cell such as LDH (~160,000 Da), (b) the uptake of modestly large labels (HRP; ~40,000 Da), and 
(c) the uptake of very small markers such as EB (~400 Da). We have not yet fully explored the 
nature of membrane breaches repaired by PEG based on the MW of the markers. Our impression 
is that the smaller the MW of the label, the more intensive the labeling (as one might expect) in 
injured cord or brain in situ, or spinal cord in organ culture (Shi and Borgens, 2000)—though the 
overall spread of the label within the tissue is a more complicated and paradoxical issue. 
 
We have not quantitatively established this by comparison however. Rather we have begun 
investigations to directly observe the imperfections in the living cell membrane using atomic 
force microscopy (AFM), where the AFM tip can be used to produce a rigorously controlled 
nanopuncture to the membrane—and then backed away from the insult to image it. Already this 
procedure has been used to image neuron cell death in real time, and the “exsanguination” of 
cytosol after mechanical injury in living DRG and Sympathetic ganglion cells in vitro. The 
puncture to living nerve membrane using the AFM cantilever tip was precisely controlled to be 
50 nm wide and 400 nm deep and a single puncture or slice killed the cell within 0.5 h. A pool of 
degraded cytoplasm formed (and progressively increased in size) on the substrate coincident with 
the collapse of the cell body (McNalley and Borgens, 2003). Our ongoing study is to image 
polymer-mediated sealing with AFM technique. 
 
Sealing and Fusion of Membranes using Inorganic Polymers 
 
Taken together these investigations suggest a characteristic, but generalized, mechanism of PEG 
action in reversing or eliminating cell and tissue necrosis after mechanical injury is via a “repair” 
of the compromised membranes This reconstitution of the membrane enables it to function, once 
again, as an effective “fence” preventing sufficient co-mingling of the solutes of the intracellular 
and extracellular compartments and permitting action potential conduction in excitable cells (Shi 
and Borgens, 1999). These factors act in concert to provide protection in damaged cells from 
progressive deterioration. 
 
PEG as a Fusogen and Agent of Membrane Repair 
 
As revealed in this study of TBI, and in previous studies of SCI, an injectable, water-soluble 
PEG possesses a unique ability to repair cell membranes. Indeed, transected axons of adult 
guinea pig white matter can be functionally and anatomically reconnected (i.e., fused). 
Originally, this capability was first exploited to induce the formation of hybridomas during the 
production of monoclonal antibodies, as well as facilitating vesicular fusion in model membrane 
studies (Lee and Lentz, 1997; Ahkong et al., 1987; Davidson et al., 1976; O’Lague and Huttner, 
1980; Nakajima and Ikada, 1994). Over 18 years ago, individual giant axons of crayfish and 
earthworm were fused with PEG following complete transection (Bittner et al., 1986; Krause and 
Bittner, 1990; Krause et al., 1991). Membrane fusion occurs when adjacent membranes touch in 
the presence of PEG and this appears to be a prerequisite to the complete fusion of the 
plasmalemma and the mixing of the cytoplasm of fused cells (Ahkong et al., 1987). It is thought 
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that acute dehydration of the fusing plasmalemmas permits glycol/protein/lipidic structures to 
resolve into each other at the outer membrane leaflet first and the inner membrane leaflet 
subsequently (Lee and Lentz, 1997), although the exact biophysical mechanisms underlying 
fusion and repair of membranes is still an active area of investigation (Lee and Lentz, 1997; 
Borgens, 2003). After more than 25 years of investigation of the fusogenic properties of certain 
polymers and non-ionic surfactants, it is still an incompletely understood area of membrane 
physics.  
 
We hasten to add that the agreed upon mechanisms of cell fusion—which involves the polymer 
mediation of the structure of membrane water, and the resolution/ intermingling of the lipid 
phase of the bilayer may not be typical of the repair of minor mechanical defects in membranes. 
It is likely that “fusion” and “repair” processes may share, and differ, in their mechanisms at the 
membrane—altogether an area still ripe for investigation. In any event, organ culture 
experiments using isolated spinal cord of guinea pigs revealed that a short duration (~2 min) 
application of PEG could fuse previously severed myelinated axons in completely transected 
spinal cords sufficient to permit the diffusion of intracellular markers throughout the reconnected 
segments (Shi et al., 1999). Using similar organ cultured cords, PEG was able to immediately 
recover conduction of action potentials lost after a standardized crush lesion (Shi and Borgens, 
1999). Since the repair of cells secondary to crush or contusion lesions is of more clinical 
relevance, these data set the stage for testing of topically applied, and intravenous applications of 
polymers in whole animal neurotrauma studies (Borgens, 2003). 
 
Clinical Implications of Cell Fusion and Repair by Polymers 
 
Topical and intravenous administration of PEG to spinal cord injury models in adult guinea pigs 
has resulted in significant sparing of white matter, recovery of behavioral functioning, and 
recovery of conduction through the lesion (Borgens and Shi, 2000; Borgens and Bohnert, 2001; 
Borgens et al., 2002). We have traced the distribution of fluorescently decorated PEG in spinal 
cord injured animals after intravenous, intraperitoneal, subcutaneous, and topical applications. 
We were unable to suggest that any one means of administration was better than another at 
labeling lesioned areas of the spinal cord (Borgens and Bohnert, 2001). This further suggests that 
once the polymer gains access to the vasculature, it targets regions of soft tissue damage, but 
does not accumulate or linger in undamaged tissues since fluorescent PEG is not observed in 
various control applications (Borgens and Bohnert, 2001; Borgens, 2003). In crushed peripheral 
nerve, it was required to inject PEG beneath the perineural sheath near the lesion to affect 
physiological and functional recovery in a sciatic/gastrocnemius muscle injury model 
(Donaldson et al., 2002). Thus, it appears that administration of this agent is not problematic.  
The strong safety record of PEG administration in human medicine (Working et al., 1997) 
suggests clinical possibilities for the use of this and other surfactants as potential therapies for 
clinical neurotrauma. 
 
Recently, encouraging results were seen with both intravenous PEG and Poloxamer 188 injection 
in dogs with severe (neurologically complete) naturally occurring paraplegia (Laverty et al, 
2004). Significant and rapid recovery of several outcome measures in dogs, including: deep and 
superficial pain, ambulation, proprioception, and evoked potentials, was consistent with the 
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functional recovery data reported in spinal injured guinea pigs. We now believe PEG may likely 




The movement of intravenously applied PEG across both the damaged and (likely) intact blood–
brain barrier remains to be better understood. In damaged brains—the movement of decorated 
PEG into the CNS compartment as shown here for brain and in spinal cord is clear (Borgens and 
Bohnert, 2001). In other experiments, PEG application was delayed for 8–12 h after injury and 
still facilitated sealing. Polymer administration (PEG and Poloxamer 188) to clinical cases of 
paraplegia produced behavioral recovery even when the intravenous injections were made ~72 h 
post-injury—a time when the BBB would been expected to again be intact. PEG may even play a 
role in sealing this barrier between the CNS and PNS. We have preliminary evidence that PEG 
indeed can seal endothelium. A drying of the wounds during laminectomy procedures (by 
reducing capillary seepage) was routinely observed, but not reported, when PEG was applied 
directly to the spinal cord and surrounding tissues in guinea pig and clinical cases of paraplegia 
in dog (Borgens and Shi, 2000; Laverty et al., 2004). This consistent observation prompted the 
investigation of endothelial sealing by polymers. These data, further details of the movement of 
PEG after the BBB has spontaneously repaired, chronic TBI, and a more detailed evaluation of 
cell death and polymer “rescue” in situ through the use of a marker for degenerating end bulbs of 






We thank Dr. Jian Luo and Deborah Bohnert for their expert assistance in technical matters, 
Stacey Foyler for manuscript preparation, and Kimberly Harrington for the illustrations. We 
acknowledge financial support from the State of Indiana and Mari Hulman George. Financial 
support was also provided by Purdue University Neuroscience GAANN Fellowship (to A.O.K.), 
National Science Foundation (HRD-022-7992 to B.D. and R.B.B.) and the support of the CPR 
by Intel Corporation for the generous gifts of computer equipment. We acknowledge the expert 
assistance of Dr. John Povlishock and his laboratory, in particular Richard Singleton, for their 





AESCHBACHER, M., REINHARDT, C.A., and ZBINDEN, G. (1986). A rapid cell membrane 
permeability test using fluorescent dyes and flow cytometry. Cell Biol. Toxicol. 2, 247–255. 
 
AHKONG, Q.F., DESMAZES, J.P., GEORGESCAULD, D., et al. (1987). Movements of 





BAJAJ, C.L., PASCUCCI, V., and SCHIKORE, D.R. (1997). The contour spectrum. 
Proceedings of the 1997 IEEE Visualization Conference, 167–173, Oct. 1997, Phoenix, AZ. 
 
BITTNER, G.D., BALLINGER, M.L., and RAYMOND, M.A. (1986). Reconnection of severed 
nerve axons with polyethylene glycol. Brain Res. 367, 351–355. 
 
BORGENS, R.B. (1988). Voltage gradients and ionic currents in injured and regenerating axons. 
Adv. Neurol. 47, 51–66. 
 
BORGENS, R.B. (2001). Cellular engineering: molecular repair of membranes to rescue cells of 
the damaged nervous system. Neurosurgery 49, 370–379. 
 
BORGENS, R.B. (2003). Restoring function to the injured human spinal cord, in: Adv Anat 
Embryol Cell Biology. P. Beck, B. Christ, W. Kriz, et al. (eds), Springer: Heidelberg, pps. III–
IV,1–155. 
 
BORGENS, R.B., and SHI, R. (2000). Immediate recovery from spinal cord injury through 
molecular repair of nerve membranes with polyethylene glycol. FASEB 14, 27–35. 
 
BORGENS, R.B., and BOHNERT, D. (2001). Rapid recovery from spinal cord injury following 
subcutaneously administered polyethylene glycol. J. Neurosci. Res. 66, 1179–1186. 
 
BORGENS, R.B., BLIGHT, A.R., and MURPHY, D.J. (1986). Axonal regeneration in spinal 
cord injury: a perspective and new technique. J. Comp. Neurol. 250, 157–167. 
 
BORGENS, R.B., SHI, R., and BOHNERT, D. (2002). Behavioral recovery from spinal cord 
injury following delayed application of polyethylene glycol. J. Exp. Biol. 205, 1–12. 
 
BUKI, A., FARKAS, O., DOCZI, T., et al. (2003). Preinjury administration of the calpain 
inhibitor mdl-28170 attenuates traumatically induced axonal injury. J. Neurotrauma 20, 261–268. 
 
CERNAK, I., CHAPMAN, S.M., HAMLIN, G.P., et al. (2002). Temporal characterisation of 
pro- and anti-apoptotic mechanisms following diffuse traumatic brain injury in rats. J. Clin. 
Neurosci. 9, 565–572. 
 
DAVIDSON, R.L., O’MALLEY, K.A., and WHEELER, T.B. (1976). Induction of mammalian 
somatic cell hybridization by polyethylene glycol. Somat. Cell Genet. 2, 271–280. 
 
DEY, C.S., and MAJUMDER, G.C. (1988). A simple quantitative method of estimation of cell-
intactness based on ethidium bromide fluorescence. Biochem. Int. 17, 367–374. 
 
DONALDSON, J., SHI, R., and BORGENS, R. (2002). Polyethylene glycol rapidly restores 




DUERSTOCK, B.S., BAJAJ, C.L., PASCUCCI, V., et al. (2000). Advances in three-
dimensional reconstruction of the experimental spinal cord injury. Comput. Med. Imaging 
Graph. 24, 389–406. 
 
DUERSTOCK, B.S., BAJAJ, C.L., and BORGENS, R.B. (2003). A comparative study of the 
quantitative accuracy of three-dimensional reconstructions of spinal cord from serial histological 
sections. J. Microsc. 210, 138–148. 
 
FENG, Y., FRATKIN, J.D., and LEBLANC, M.H. (2003). Inhibiting caspase-8 after injury 
reduces hypoxic-ischemic brain injury in the newborn rat. Eur. J. Pharmacol. 481, 169–173. 
 
FODA, M.A., and MARMAROU, A. (1994). A new model of diffuse brain injury in rats. Part ii: 
Morphological characterization. J. Neurosurg. 80, 301–313. 
 
GWAG, B.J., CANZONIERO, L.M., SENSI, S.L., et al. (1999). Calcium ionophores can induce 
either apoptosis or necrosis in cultured cortical neurons. Neuroscience. 90, 1339–1348. 
 
HEATH, D.L., and VINK, R. (1996). Traumatic brain axonal injury produces sustained decline 
in intracellular free magnesium concentration. Brain Res. 738, 150–153. 
 
KEANE, R.W., KRAYDIEH, S., LOTOCKI, G., et al. (2001). Apoptotic and anti-apoptotic 
mechanisms following spinal cord injury. J. Neuropathol. Exp. Neurol. 60, 422–429. 
 
KOENIG, E., and GIUDITTA, A., (1999). Protein-synthesizing machinery in the axon 
compartment. Neuroscience 89, 5–15. 
 
KOIZUMI, H., and POVLISHOCK, J.T (1998). Posttraumatic hypothermia in the treatment of 
axonal damage in an animal model of traumatic axonal injury. J. Neurosurg. 89, 303–309. 
 
KRAUSE, T.L., and BITTNER, G.D. (1990). Rapid morphological fusion of severed myelinated 
axons by polyethylene glycol. Proc. Natl. Acad. Sci. USA 87, 1471–1475. 
 
KRAUSE, T.L., MARQUIS, R.E., LYCKMAN, A.W., et al. (1991). Rapid artificial restoration 
of electrical continuity across a crush lesion of a giant axon. Brain Res. 561, 350–353. 
 
LAVERTY, P.H., LESKOVAR, A., BREUR, G.J., et al. (2004). A preliminary study of 
intravenous surfactants in paraplegic dogs: polymer therapy in canine clinical SCI. J. 
Neurotrauma 21, 1767–1777. 
 
LEE, J., and LENTZ, B.R. (1997). Evolution of lipidic structures during model membrane fusion 
and the relation of this process to cell membrane fusion. Biochemistry 36, 6251–6259. 
 
LUO, J., BORGENS, R.B., and SHI, R. (2002). Polyethylene glycol immediately repairs 
neuronal membranes and inhibits free radical production after acute spinal cord injury. J. 




LUO, J., BORGENS, R., and SHI, R. (2004). Polyethylene glycol improves function and reduces 
oxidative stress in synaptosomal preparations following spinal cord injury. J. Neurotrauma 21, 
994–1007. 
 
MARGULIES, S.S., and THIBAULT, L.E. (1992). A proposed tolerance criterion for diffuse 
axonal injury in man. J. Biomech. 25, 917–923. 
 
MARMAROU, A., FODA, M.A., VAN DEN BRINK, W., et al. (1994). A new model of diffuse 
brain injury in rats. Part 1: Pathophysiology and biomechanics. J. Neurosurg. 80, 291–300. 
 
MCNALLY, H.A., and BORGENS, R.B. (2004). Three-dimensional imagining of living and 
dying neurons with atomic force microscopy. J. Neurocytol. 33, 251–258. 
 
MOVSESYAN, V.A., YAKOVLEV, A.G., FAN, L., et al. (2001). Effect of serine protease 
inhibitors on posttraumatic brain injury and neuronal apoptosis. Exp. Neurol. 167, 366–375. 
 
NAKAJIMA, N., and IKADA, Y. (1994). Fusogenic activity of various water-soluble polymers. 
J. Biomater. Sci. Polymer Ed. 6, 751–759. 
 
NAWASHIRO, H., SHIMA, K., and CHIGASAKI, H. (1995). Immediate cerebrovascular 
responses to closed head injury in the rat. J. Neurotrauma 12, 189–197. 
 
O’LAGUE, P.H., and HUTTNER, S.L. (1980). Physiological and morphological studies of rat 
pheochromocytoma cells (pc12) chemically fused and grown in culture. Proc. Natl. Acad. Sci. 
USA 77, 1701–1705. 
 
PIPER, M., and HOLT, C. (2004). RNA translation in axons. Annu. Rev. Cell. Dev. Biol. 20, 
505–523. 
 
POVLISHOCK, J.T., MARMAROU, A., MCINTOSH, T., et al. (1997). Impact acceleration 
injury in the rat: evidence for focal axolemmal change and related neurofilament sidearm 
alteration. J. Neuropathol. Exp. Neurol. 56, 347–359. 
 
RAGHUPATHI, R., GRAHAM, D.I., and MCINTOSH, T.K. (2000). Apoptosis after traumatic 
brain injury. J. Neurotrauma 17, 927–938. 
 
ROY, M., and SAPOLSKY, R. (1999). Neuronal apoptosis in acute necrotic insults: why is this 
subject such a mess? Trends Neurosci. 22, 419–422. 
 
SHAPIRA, Y., YADID, G., COTEV, S., et al. (1989). Accumulation of calcium in the brain 
following head trauma. Neurol. Res. 11, 169–172. 
 
SHI, R., and BORGENS, R.B. (1999). Acute repair of crushed guinea pig spinal cord by 




SHI, R., and PRYOR, J.D. (2000). Temperature dependence of membrane sealing following 
transection in mammalian spinal cord axons. Neuroscience 98, 157–166. 
 
SHI, R., and BORGENS, R.B. (2000). Anatomical repair of nerve membranes in crushed 
mammalian spinal cord with polyethylene glycol. J. Neurocytol. 29, 633–643. 
 
SHI, R., BORGENS, R.B., and BLIGHT, A.R. (1999). Functional reconnection of severed 
mammalian spinal cord axons with polyethylene glycol. J. Neurotrauma 16, 727–738. 
 
SINGLETON, R.H., and POVLISHOCK, J.T. (2004). Identification and characterization of 
heterogeneous neuronal injury and death in regions of diffuse brain injury: evidence for multiple 
independent injury phenotypes. J. Neurosci. 24, 3543–3553. 
 
SUN-KYUNG, L., and HOLLENBECK, P.J. (1995). Organization and translation of mRNA in 
sympathetic axons. J. Cell Sci. 116, 4467–4478. 
 
TENG, Y.D., CHOI, H., ONARIO, R.C., et al. (2004). Minocycline inhibits contusion-triggered 
mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. 
Proc. Natl. Acad. Sci. USA 101, 3071–3076. 
 
THURMAN, D.J., ALVERSON, C., DUNN, K.P., et al. (1999). Traumatic brain injury in the 
United States: a public health perspective. J. Head Trauma Rehabil. 14, 602–615. 
 
VERSACE, J. (1971). A Review of the Severity Index. Society of Automotive Engineers: New 
York. 
 
VINK, R., NIMMO, A.J., and CERNAK, I. (2001). An overview of new and novel 
pharmacotherapies for use in traumatic brain injury. Clin. Exp. Pharmacol. Physiol. 28, 919–921. 
 
WORKING, P., NEWMAN, M., JOHNSON, J., et al. (1997). Safety of poly(ethyleneglycol) and 
poly(ethyleneglycol) derivatives, in: Poly(ethyleneglycol) Chemistry and Biological 
Applications. J.M. Harris and S. Zalipsky (eds), American Chemistry Society: Washington, DC., 
pps. 45–57. 
 
ZIPFEL, G.J., BABCOCK, D.J., et al. (2000). Neuronal apoptosis after CNS injury: the role 
 
